| Source HCPCS Code |
|
Target NDC Code |
Q5136
Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg
|
⇄
|
61314-0228-94
WYOST 120 MG/1.7 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1.7 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q5136
Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg
|
⇄
|
61314-0240-63
JUBBONTI 60 MG/ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
10/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q5136
Inj. denosumab-bbdz, 1 mg
|
⇄
|
61314-0228-94
Wyost
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q5136
Inj. denosumab-bbdz, 1 mg
|
⇄
|
61314-0240-63
Jubbonti
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|